IP Library Patent Application 11561520
Patent Application
App. No. 11/561,520

Use of Fullerenes to Oxidize Reduced Redox Proteins

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
11/561,520
Abstract

Disclosed herein is a method of oxidizing a reduced redox protein by contacting an aqueous solution containing the reduced redox protein with a water-soluble substituted fullerene under conditions in which the water-soluble substituted fullerene can oxidize the reduced redox protein. The redox protein can be cytochrome c.

Claims (12)

1 . A method of oxidizing a reduced redox protein, comprising:

contacting an aqueous solution containing the reduced redox protein with a water-soluble substituted fullerene under conditions in which the water-soluble substituted fullerene can oxidize the reduced redox protein.

2 . The method of claim 1 , wherein the redox protein is a metalloprotein.

3 . The method of claim 2 , wherein the metalloprotein is a heme protein.

4 . The method of claim 3 , wherein the heme protein is a cytochrome.

5 . The method of claim 4 , wherein the cytochrome is cytochrome c.

6 . The method of claim 1 , wherein the redox protein is a flavoprotein.

7 . The method of claim 1 , wherein the water-soluble substituted fullerene is a dendrofullerene.

8 . The method of claim 7 , wherein the dendrofullerene is selected from the group consisting of DF-1, DF-1 Mini, PW71, PW75, PW79, PW80, PW85, PW87, PW88, PW104, PW114, and PW130.

9 . The method of claim 1 , wherein the water-soluble substituted fullerene is selected from the group consisting of C3 and esters thereof.

10 . The method of claim 9 , wherein the ester of C3 is selected from the group consisting of FB01, FB02, FB03, and FB10.

11 . The method of claim 1 , wherein the contacting step is performed in vivo.

Assignments (6)
RELEASE OF SECURITY INTEREST Recorded Feb 6, 2015
From: HANSEN MEDICAL, INC.
To: LUNA INNOVATIONS INCORPORATED
Reel/Frame 034914/0407 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 2, 2015
From: TEGO BIOSCIENCES CORPORATION
To: LUNA INNOVATIONS INCORPORATED
Reel/Frame 034872/0894 →
SECURITY AGREEMENT Recorded Feb 25, 2010
From: LUNA INNOVATIONS INCORPORATED
To: SILICON VALLEY BANK
Reel/Frame 023985/0718 →
SECURITY AGREEMENT Recorded Jan 14, 2010
From: LUNA INNOVATIONS INCORPORATED
To: HANSEN MEDICAL, INC.
Reel/Frame 023792/0388 →
CHANGE OF NAME Recorded Mar 20, 2008
From: C SIXTY ACQUISITION CORPORATION
To: TEGO BIOSCIENCES CORPORATION
Reel/Frame 020679/0534 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 14, 2007
From: C SIXTY, INC.
To: C SIXTY ACQUISITION CORPORATION
Reel/Frame 020243/0318 →